Isomeric Pharmacy Recalls Injection Vials Due to Sterility Concerns
Isomeric Pharmacy Solution, LLC is recalling 851 vials of a multi-dose injection product because production processes cannot assure sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable product, which carries a significant risk of serious injury or death if contaminated.
Plain-English summary
Isomeric Pharmacy Solution, LLC is recalling 851 vials of Cyanocobalamin 1 mg/mL/ Methionine 25 mg/mL/ Inositol 50 mg/mL/ Choline 50 mg/mL, 30 mL Multi-Dose Vial For Injection. The product is prescription-only and was distributed nationwide in the USA and Puerto Rico.
The recall was initiated due to a lack of assurance of sterility. The firm identified concerns with production processes that cannot guarantee the sterility of products intended to be sterile. The affected lots are 09003, 11003, 11035, 11039, 12002, and 12012, with expiration dates ranging from April 17, 2017, to July 30, 2017.
Healthcare providers and patients should stop using the affected vials and contact the recalling firm for further instructions. The FDA has classified this as a Class II recall.
The recalled product
- Product
- Cyanocobalamin 1 mg/mL/ Methionine 25 mg/mL/ Inositol 50 mg/mL/ Choline 50 mg/mL, 30 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Drive, SLC, UT 84109, Part # 1101, barcode 3 70285 11013 9.
- Manufacturer
- Isomeric Pharmacy Solution, LLC
- Category
- Drug — Injectable
- Affected units
- 851
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot #s: 09003
- Exp 04/17/17
- 11003
- Exp 06/21/17
- 11035
- Exp 07/03/17
- 11039
- Exp 07/05/17
- 12002
- Exp 07/23/17
- 12012
- Exp 07/30/17.
Distribution
Part of a larger recall action
This product is one of 7 recalled by Isomeric Pharmacy Solution, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Isomeric Pharmacy Solution, LLC
See all →- SevereIsomeric Pharmacy Recalls Methylprednisolone Acetate Injection Vials for Sterility Concerns
FDA (Drugs) · 2017-05-03
- SevereIsomeric Pharmacy Recalls Triamcinolone Acetonide Injection Vials for Sterility Concerns
FDA (Drugs) · 2017-05-03
- SevereIsomeric Pharmacy Recalls Phenylephrine and Tropicamide Ophthalmic Drops
FDA (Drugs) · 2017-05-03
- SevereIsomeric Pharmacy Recalls Methylprednisolone Acetate Injection Vials for Sterility Concerns
FDA (Drugs) · 2017-05-03
- HighIsomeric Pharmacy Recalls Triamcinolone Diacetate Vials Due to Sterility Concerns
FDA (Drugs) · 2017-05-03
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- Moderate
- SevereKey Pharmacy Recalls Cyanocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereVitalab Pharmacy Recalls Sterile Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SevereAxia Pharmaceutical Recalls Cyanocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2020-03-11
- HighCyanocobalamin Injectable Vials Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-06-01
- SevereUS Compounding Recalls MIC Combo Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25